1. Home
  2. Labeler Index
  3. Carilion Materials Management
  4. NDC Product Code: 68151-5004 Ranexa

NDC 68151-5004 Ranexa

View Dosage, Usage, Ingredients, Routes, UNII

Table of Contents

  1. Product Information
  2. Product Packages
  3. Product Characteristics
  4. What is NDC 68151-5004?
  5. Ranexa Uses
  6. Active Ingredients UNII Codes
  7. Inactive Ingredients UNII Codes
  8. NDC to RxNorm Crosswalk

Product Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.
NDC Product Code:
68151-5004
Proprietary Name:
Ranexa
Product Type: [3]
INACTIVATED PRODUCT and EXCLUDED the from NDC Directory
Labeler Name: [5]
Carilion Materials Management
Labeler Code:
68151
Product Label ID:
e038f963-d78f-460e-a11f-46f224061505
Start Marketing Date: [9]
01-27-2006
Listing Expiration Date: [11]
12-31-2018
Exclude Flag: [12]
I
Code Structure:
Code Navigator:

Product Characteristics

Color(s):
ORANGE (C48331 - LIGHT ORANGE)
Shape:
OVAL (C48345)
Size(s):
17 MM
Imprint(s):
GSI500
Score:
1

Product Packages

NDC Code 68151-5004-1

Package Description: 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 PACKAGE

Product Details

What is NDC 68151-5004?

The NDC code 68151-5004 is assigned by the FDA to the product Ranexa which is product labeled by Carilion Materials Management. The product's dosage form is . The product is distributed in a single package with assigned NDC code 68151-5004-1 1 tablet, film coated, extended release in 1 package . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

What are the uses for Ranexa?

Ranolazine is used to treat a certain type of chest pain (chronic stable angina). It decreases the number of times you may get chest pain. Relieving symptoms of angina can increase your ability to exercise and perform strenuous work. Ranolazine works differently than other drugs for angina, so it can be used with your other angina medications (including nitrates, calcium channel blockers such as amlodipine, beta blockers such as metoprolol). It is thought to work by improving how well the heart uses oxygen so that it can do more work with less oxygen.

Which are Ranexa UNII Codes?

The UNII codes for the active ingredients in this product are:

Which are Ranexa Inactive Ingredients UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

What is the NDC to RxNorm Crosswalk for Ranexa?

RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
  • RxCUI: 616749 - ranolazine 500 MG 12HR Extended Release Oral Tablet
  • RxCUI: 616749 - 12 HR ranolazine 500 MG Extended Release Oral Tablet
  • RxCUI: 616749 - ranolazine 500 MG 12 HR Extended Release Oral Tablet
  • RxCUI: 860738 - Ranexa 500 MG 12HR Extended Release Oral Tablet
  • RxCUI: 860738 - 12 HR ranolazine 500 MG Extended Release Oral Tablet [Ranexa]

* Please review the disclaimer below.

Product Footnotes

[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".